|
| Status |
Public on May 01, 2010 |
| Title |
GSK-3 inhibitor treatment effect on MLL leukemia cell |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
Human leukemia cell line RS4.11 was treated with GSK-3 inhibitor SB216763 for 20 hours. Gene expression profiling was performed to analyze genes affected by GSK-3 inhibition.
|
| |
|
| Overall design |
Human leukemia cell line RS4.11 was grown in vitro and treated with 10 uM GSK-3 inhibitor SB216763 or solvent DMSO for 20 hours. Total RNA was extracted and microarray analysis was performed. Two controls and three inhibitor treatment samples were analyzed.
|
| |
|
| Contributor(s) |
Wang Z, Cleary ML |
| Citation(s) |
20541704 |
| Submission date |
Jan 04, 2010 |
| Last update date |
Jul 26, 2018 |
| Contact name |
Michael L Cleary |
| E-mail(s) |
mcleary@stanford.edu
|
| Phone |
(650) 723-5471
|
| Fax |
(650) 498-6222
|
| URL |
http:// http://med.stanford.edu/profiles/pathology/researcher/Michael_Cleary/ At Stanford
|
| Organization name |
Stanford University
|
| Department |
Pathology
|
| Street address |
Room L232, Stanford Medical Center
|
| City |
Stanford |
| State/province |
CA |
| ZIP/Postal code |
94305 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL6244 |
[HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] |
|
| Samples (5)
|
| GSM492848 |
GSK-3 inhibitor effect on MLL leukemia cells - 2 |
| GSM492849 |
GSK-3 inhibitor effect on MLL leukemia cells - 3 |
|
| Relations |
| BioProject |
PRJNA122197 |
Less...
More...